Efficacy of short‑term intensive treatment with insulin pump to improve islet β‑cell function in newly diagnosed type 2 diabetes via inhibition of oxidative stress

  • Authors:
    • Hai‑Tong Liu
    • Yan Gao
  • View Affiliations

  • Published online on: July 26, 2019     https://doi.org/10.3892/etm.2019.7821
  • Pages: 2293-2298
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study (Chinese Trial Registry GTB7027) assessed the effects of short‑term intensive treatment with insulin pump on islet cell function in patients with newly diagnosed type 2 diabetes and the possible mechanism. A total of 100 patients newly diagnosed with type 2 diabetes and hospitalized between January 2016 and December 2017 were divided into a control and an experimental group (n=50 in each group). The subjects of the control group were administered multiple insulin injections for intensive treatment, while the experimental group received short‑term intensive treatment with an insulin pump. Analysis of blood parameters, including lipids and glucose, as well as islet β‑cell function were performed. The level of reactive oxygen species (ROS) in the peripheral blood mononuclear cells (PBMCs) from the patients was also measured. Oxidative stress indicators, including serum malondialdehyde (MDA) and superoxide dismutase (SOD), were also examined to explore the possible mechanism. The mRNA expression of heme oxygenase 1 (HO‑1) and nuclear factor erythroid 2‑related factor 2 (Nrf2) in PBMCs were analyzed by reverse transcription‑quantitative PCR. The results indicated that the blood lipid levels were significantly improved in the two groups at two weeks, while the experimental group had significantly lower levels of total cholesterol and triglyceride, as well as low‑ and high‑density lipoprotein cholesterol. The function of islet β‑cells was significantly improved in the two groups. The insulin secretion index [homeostasis model assessment (HOMA) of β‑cell function] in the experimental group was higher, while the insulin resistance (IR) index (HOMA of IR) was significantly lower than that in the control group. The serum MDA level in the experimental group was significantly lower and the SOD level was significantly higher compared with that in the control group. Following treatment, the level of ROS in diabetic PBMCs was significantly reduced, and the transcription level of HO‑1 and Nrf2 were also significantly reduced (P<0.05). These results demonstrated that short‑term intensive treatment with an insulin pump significantly improved lipid and blood glucose metabolism to protect islet function as well as significantly reducing the level of oxidative stress in patients with newly diagnosed type 2 diabetes.

References

1 

Urakami T, Suzuki J, Mugishima H, Amemiya S, Sugihara S, Kawamura T, Kikuchi T, Sasaki N, Matsuura N and Kitagawa T: Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan. Pediatr Endocrinol Rev. 10 (Suppl 1):S51–S61. 2012.

2 

Halban PA, Polonsky KS, Bowden DW, Hawkins MA, Ling C, Mather KJ, Powers AC, Rhodes CJ, Sussel L and Weir GC: β-cell failure in type 2 diabetes: Postulated mechanisms and prospects for prevention and treatment. J Clin Endocrinol Metab. 99:1983–1992. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Mu J, Woods J, Zhou YP, Roy RS, Li Z, Zycband E, Feng Y, Zhu L, Li C, Howard AD, et al: Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes. Diabetes. 55:1695–1704. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Robertson RP, Harmon J, Tran PO, Tanaka Y and Takahashi H: Glucose toxicity in beta-cells: Type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. 52:581–587. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Retnakaran R: Novel strategies for inducing glycemic remission during the honeymoon phase of type 2 diabetes. Can J Diabetes. 39:(Suppl). S142–S147. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Marchetti P, Lupi R, Del Guerra S, Bugliani M, D'Aleo V, Occhipinti M, Boggi U, Marselli L and Masini M: Goals of treatment for type 2 diabetes beta-cell preservation for glycemic control. Diabetes Care. 32 (Suppl 2):S178–S183. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH and Knowler WC: Plasma glucose and prediction of microvascular disease and mortality: Evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care. 23:1113–1118. 2000. View Article : Google Scholar : PubMed/NCBI

8 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

9 

Chiu KC, Chu A, Go VL and Saad MF: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 79:820–825. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Meier JJ and Bonadonna RC: Role of reduced β-cell mass versus impaired β-cell function in the pathogenesis of type 2 diabetes. Diabetes Care. 36 (Suppl 2):S113–S119. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Rorsman P and Ashcroft FM: Pancreatic β-cell electrical activity and insulin secretion: Of mice and men. Physiol Rev. 98:117–214. 2018. View Article : Google Scholar : PubMed/NCBI

12 

Robertson RP: Beta-Cell deterioration during diabetes: What's in the gun? Trends Endocrinol Metab. 20:388–393. 2009. View Article : Google Scholar : PubMed/NCBI

13 

White MG, Shaw JA and Taylor R: Type 2 diabetes: The pathologic basis of reversible β-Cell dysfunction. Diabetes Care. 39:2080–2088. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Steven S and Taylor R: Restoring normoglycaemia by use of a very low calorie diet in long- and short-duration type 2 diabetes. Diabet Med. 32:1149–1155. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Robertson RP, Harmon J, Tran PO and Poitout V: Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 53 (Suppl 1):S119–S124. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Jung KY, Kim KM and Lim S: Therapeutic approaches for preserving or restoring pancreatic β-Cell function and mass. Diabetes Metab J. 38:426–436. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Mizukami H, Takahashi K, Inaba W, Osonoi S, Kamata K, Tsuboi K and Yagihashi S: Age-associated changes of islet endocrine cells and the effects of body mass index in Japanese. J Diabetes Investig. 5:38–47. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Dragun Z, Filipović Marijić V, Krasnići N, Ramani S, Valić D, Rebok K, Kostov V, Jordanova M and Erk M: Malondialdehyde concentrations in the intestine and gills of Vardar chub (Squalius vardarensis Karaman) as indicator of lipid peroxidation. Environ Sci Pollut Res Int. 24:16917–16926. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Zhao QB, Wang HF, Sun CF, Ma AQ and Cui CC: Effect of short-term intensive treatment with insulin pump on beta cell function and the mechanism of oxidative stress in newly diagnosed type 2 diabetic patients. Nan Fang Yi Ke Da Xue Xue Bao. 27:1878–1879. 2007.(In Chinese). PubMed/NCBI

20 

Bao W, Song F, Li X, Rong S, Yang W, Zhang M, Yao P, Hao L, Yang N, Hu FB and Liu L: Plasma Heme Oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus. PLoS One. 5:e123712010. View Article : Google Scholar : PubMed/NCBI

21 

Fukushima-Uesaka H, Saito Y, Maekawa K, Kamatani N, Kajio H, Kuzuya N, Noda M, Yasuda K and Sawada J: Genetic variations and haplotype structures of transcriptional factor Nrf2 and its cytosolic reservoir protein Keap1 in Japanese. Drug Metab Pharmacokinet. 22:212–219. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liu, H., & Liu, H. (2019). Efficacy of short‑term intensive treatment with insulin pump to improve islet β‑cell function in newly diagnosed type 2 diabetes via inhibition of oxidative stress. Experimental and Therapeutic Medicine, 18, 2293-2298. https://doi.org/10.3892/etm.2019.7821
MLA
Liu, H., Gao, Y."Efficacy of short‑term intensive treatment with insulin pump to improve islet β‑cell function in newly diagnosed type 2 diabetes via inhibition of oxidative stress". Experimental and Therapeutic Medicine 18.3 (2019): 2293-2298.
Chicago
Liu, H., Gao, Y."Efficacy of short‑term intensive treatment with insulin pump to improve islet β‑cell function in newly diagnosed type 2 diabetes via inhibition of oxidative stress". Experimental and Therapeutic Medicine 18, no. 3 (2019): 2293-2298. https://doi.org/10.3892/etm.2019.7821